AYTU 10-Q: SEC filing
Aytu BioPharma
Filed with the SEC on · accession 0001437749-26-037188
AYTU filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +2.2% by the first close after the filing.
Summary of the filing
Aytu BioPharma filed its quarterly 10-Q report for the fiscal quarter ended September 30, 2026, disclosing routine financial statements, warrant reclassifications from liability to equity, and an ERC accrual.
Key details
How AYTU stock reacted
Close before
$1.78
Nov 13, 2026
First close after
+2.25%
$1.82
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AYTU, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AYTU?
Click hereFrequently asked questions
What did AYTU file with the SEC on Nov 16, 2026?
AYTU filed a 10-Q (SEC filing). Aytu BioPharma filed its quarterly 10-Q report for the fiscal quarter ended September 30, 2026, disclosing routine financial statements, warrant reclassifications from liability to equity, and an ERC accrual.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did AYTU stock react to this filing?
AYTU closed at $1.78 before the filing and $1.82 on Nov 16, 2026 (+2.25%).
Other AYTU SEC filings
Get alerts when AYTU files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days